Email

hotez@bcm.edu

Positions

Dean for the National School of Tropical Medicine

Baylor College of Medicine
Houston, United States

Professor

Departments of Pediatrics and Molecular Virology & Microbiology
Baylor College of Medicine
Houston, Texas United States

Endowed Chair in Tropical Pediatrics

Texas Children's Hospital
Houston, Texas United States

Co-Director

Texas Children's Hospital Center for Vaccine Development
Houston, Texas United States

Founding Editor in Chief

PLOS Neglected Tropical Diseases

University Professor

Baylor University
Houston, Texas United States

Fellow in Disease and Poverty

James A. Baker III Institute for Public Policy
Rice University
Houston, Texas United States

Health Policy Scholar

Center for Medical Ethics and Health Policy
Baylor College of Medicine

Faculty-Senior Fellow

Hagler Institute for Advanced Study & Scowcroft Institute of Intl Affairs
Texas A&M University

Education

M.D. from Weill Cornell Medical College

05/1987 - New York, NY United States

Ph.D. from The Rockefeller University

05/1986 - New York, NY United States

B.A. (magna cum laude) from Yale University

05/1980 - New Haven, Connecticut United States

Professional Interests

• Drug and Vaccine Delivery
• Tropical Medicine

Websites

Projects

Coronavirus Vaccines

Development of coronavirus vaccines including vaccines administered to over 100 million people in India and Indonesia. Ongoing work includes research on a multivalent pan-coronavirus vaccine to protect against multiple coronavirus variants.

Human Hookworm Vaccine

Development of a vaccine for the more than 400 million people suffering from hookworm infection in the world today. Vaccine currently in phase 1 clinical trials in Brazil and Gabon.

Schistosomiasis Vaccine

Schistosomiasis afflicts over 200 million people around the globe and is the deadliest disease among the seven most prevalent NTDs, killing an estimated 280,000 people annually. Our vaccine is entering phase 1 clinical trials.

Chagas Disease and Leishmaniasis Vaccine

A project for the selection and discovery of antigens appropriate to advance into the development process of new vaccines to combat Chagas disease (American trypanosomiasis) and leishmaniasis.

SARS Vaccine

A new vaccine to prevent severe acute respiratory syndrome (SARS). A prototype RBD219 N1 vaccine is entering scale-up process development

Multivalent Anthelmintic Vaccine Discovery

A panhelmintic vaccine to prevent ascariasis (roundworm) and trichuris (whipworm), soil-transmitted helminths afflicting hundreds of millions of people around the world.